SPECIAL REPORTBEARISH

Four DocuSign executives sold nearly $3 million in stock in rapid succession

CEO, chief revenue officer, chief legal officer and a board member all filed stock sales within the same stretch of disclosures.

Executive takeaway

DocuSign insiders disclosed combined stock sales of roughly $2.92 million, led by CEO Allan Thygesen's $1.8 million transaction.

Newsroom graphic
CEO's sale dwarfs other DocuSign insiders combined. The four disclosed DocuSign insider sales this week, led by CEO Allan Thygesen's $1.8 million transaction, which alone exceeds the other three combined.

CEO's sale dwarfs other DocuSign insiders combined

The four disclosed DocuSign insider sales this week, led by CEO Allan Thygesen's $1.8 million transaction, which alone exceeds the other three combined.

Investing.com — All News: separate filings on Thygesen, Shaughnessy, Hansen, and Wilderotter stock sales

Use this chart

Free to embed with attribution:

<figure><a href="https://www.indy.finance/news/four-docusign-executives-sold-nearly-3-million-in-stock-in-rapid-succession"><img src="https://www.indy.finance/news/four-docusign-executives-sold-nearly-3-million-in-stock-in-rapid-succession/graphic.svg" alt="CEO's sale dwarfs other DocuSign insiders combined" width="1200" height="675"></a><figcaption>CEO's sale dwarfs other DocuSign insiders combined — <a href="https://www.indy.finance/news/four-docusign-executives-sold-nearly-3-million-in-stock-in-rapid-succession">Indy Finance</a></figcaption></figure>
Four DocuSign insiders disclosed stock sales in filings reviewed this week. CEO Allan Thygesen sold $1.8 million in shares, chief legal officer Shaughnessy sold $825,552, chief revenue officer Paula Hansen sold $227,061, and director Wilderotter sold $68,800. Combined, the four transactions total close to $2.92 million. Clustered insider selling across multiple executive roles, rather than a single officer, tends to draw more scrutiny from investors because it is harder to attribute to one person's personal liquidity needs. Many such sales are pre-scheduled under 10b5-1 trading plans set up months in advance, so the timing does not necessarily reflect a view on near-term performance. What remains unclear from the filings is whether these were pre-arranged plan sales or discretionary trades, and whether any of the four insiders still hold options or restricted stock they have not yet exercised.
What would change this view

If DocuSign's next 10-Q or proxy filing shows these sales were executed under pre-established 10b5-1 plans dated before this quarter, the cluster would read as routine rather than a signal.

Wire sources cited

Produced automatically by the INDY NEWS Desk from the public wire sources cited above, and checked against them before publication. Market commentary, not investment advice.